Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details
SPOT
SPOT

0 review

Jvion
Jvion

0 review

Categories

Solutions

Description

Product Description:
SPOT is a novel Clinician Decision Support Digital Health CE-marked medical device platform. Using AI, SPOT is able to harness information to enable the development of guidelines and predict prescriber performance to ensure safe and effective treatment of pain. SPOT supports prescribers switching patients addicted or misusing opioids to buprenorphine as part of a medication-assisted treatment regime to reduce the risk of opioid overdose death. SPOT is also used in palliative and end of life care settings to support opioid switch in cases of toxicity or unwanted side effects. In a real world, cross setting and multi-professional study in the NHS it is proven to significantly improve the confidence of opioid prescribing in users and adherence to best practice guidelines. SPOT is designed to reduce unwarranted variation and primary and secondary harms when prescribing opioids whilst supporting warranted variation of choice to align to individual situations, values and side effect profiles. SPOT is able to monitor drug usage and spend and suggest lower-cost opioids to users to reduce costs to healthcare organisations. SPOT is currently in use in the NHS.
About Doctor Flint Limited:
SPOT is the only CE-Marked, clinically-validated equianalgesic opioid converter in clinical practice, assessed against the NHS Scotland Quality Assurance Framework for Medical Device Apps, based upon the Scottish Palliative Guidelines, proven to improve adherence to guidelines and con- fidence in prescribers which is ready for national-level adoption and is currently rolled out in an NHS Board. It is designed to support prescribers during shortages associated with the COVD19 pandemic and prescribers using unfamiliar opioids. It comes with the mandated software support, updates, indemnity and ongoing clinical appraisal to continue to fulfil this the National Assurance Framework. SPOT is part of NHS Scotland's Coronavirus Toolkit in response to COVID-19 https://www.gov.scot/publications/coronavirus-covid-19-palliative-care-toolkit/
Product Description:
Jvion helps healthcare systems and providers prevent harm and lower costs through its AI-enabled prescriptive analytics solution. An industry first, the Jvion Machine™ goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients.
About Jvion:
Preventable harm is preventable. Jvion helps healthcare systems prevent patient harm and associated costs by enabling clinical staff to focus attention, resources, and individualized interventions on patients whose outcomes can be improved. Unlike traditional AI and predictive analytic solutions that merely identify high-risk patients and cause alarm fatigue, Jvion pinpoints the impactable patients who are on a risk trajectory that can be changed and provides the patient-specific recommendations that will drive to a better outcome. The Jvion Machine™ is a combination of Eigen-based mathematics, dataset of more than 16 million patients, and software that can be quickly applied to any of 50 preventable harm vectors (such as sepsis, readmissions, falls, avoidable ER visits, and pressure injuries) without the need to create new models or to have perfect data. As the leader in prescriptive analytics for preventable harm, Jvion has proven effective in clinical settings for nearly a decade, with hospitals reporting average reductions of 30% in preventable harm incidents and avoidable cost savings of $6.3 million a year.

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Use Cases

Description:
SPOT is currently in active day-to-day use in the NHS. SPOT is deployed Board-wide to all NHS Borders prescribers including pharmacists, nurses and physicians.
Pediatric use cases:

None provided

Users:
Physicians, Nurses, Independent Prescribers, Non-medical prescribers, Pharmacists
Description:
The Jvion Machine™ is a combination of Eigen-based mathematics, dataset of more than 16 million patients, and software that can be quickly applied to any of 50 preventable harm vectors (such as sepsis, readmissions, falls, avoidable ER visits, and pressure injuries) without the need to create new models or to have perfect data.
Pediatric use cases:

None provided

Users:
Nurses, Physicians, Case Managers, Care Coordinators, and other clinical resources responsible for preventing adverse events and improving clinical outcomes.

EHR Integrations

Integrations:

Other

EMR Integration & Relevant Hardware:

Use case dependent

EMRs Supported:

Would prefer not to disclose

Hardware Compatibility:

Desktop, Mobile / Tablet (native app)

Integrations:

None provided

EMR Integration & Relevant Hardware:

None provided

EMRs Supported:

None provided

Hardware Compatibility:

None provided

Client Types

None provided

Differentiators

Differentiators vs EHR Functionality:
1. Clinical Validation - multi-site cross-professional study 2. CE-Mark + MDR. All medical device regulatory approvals 3. NHS Scotland Quality Assurance Framework for Medical Device Apps Approved https://rightdecision.scot.nhs.uk/spot-safer-prescribing-of-opiooids-tool/ 4. Ability to monitor prescriber performance and identify users and areas that would benefit from retraining and eduction 5. Monitor and manage opioid drug spend 6. Customise local formulary to offer lower-cost opioids first line to manage drug spend 7. Using AI, able to predict the likelihood of individual prescriber errors and the magnitude of the error. 8. Management reports allowing benchmarking between and within organisations and clinical areas
Differentiators vs Competitors:

None provided

Differentiators vs EHR Functionality:

None provided

Differentiators vs Competitors:

None provided

Keywords

Images

1 of 1

edit-media

No images provided

Videos

1 of 1

edit-media

No videos provided

Downloads

No content provided

No content provided

Alternatives

Company Details

Founded in 2015

Founded in 2011

team illustration
Share your product comparison with your collegues.

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top